Lunai Bioworks (LNAI) Cash from Investing Activities (2011 - 2025)
Lunai Bioworks (LNAI) posted quarterly Cash from Investing Activities of -$1238.0 for Q4 2025, down 100.23% quarter-over-quarter from $544700.0 in Q3 2025.
Lunai Bioworks (LNAI) Cash from Investing Activities (2011 - 2025) Analysis & Trends
Lunai Bioworks' Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$1238.0 for Q4 2025.
- In Q4 2025, Cash from Investing Activities changed N/A year-over-year to -$1238.0; the TTM figure through Mar 2026 stood at $1.5 million (changed N/A YoY), while the FY2025 annual figure was -$500000.0, up 60.32% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$1238.0, down from $544700.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $964389.0 in Q2 2025, with the low at -$1.1 million in Q3 2023.
- The 4-year median for Cash from Investing Activities is -$22156.0 (2021), against an average of $19820.4.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities plunged 769.13% in 2024, then surged 1906.89% in 2025.
- Lunai Bioworks' Cash from Investing Activities stood at -$5156.0 in 2021, then tumbled by 1011.99% to -$57334.0 in 2023, then increased by 6.91% to -$53373.0 in 2024, then soared by 97.68% to -$1238.0 in 2025.
- Business Quant data shows LNAI's Cash from Investing Activities at -$1238.0 in Q4 2025, $544700.0 in Q3 2025, and $964389.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,238.00 |
| Dec 31, 2025 | -1,238.00 |
| Sep 30, 2025 | 544,700.00 |
| Sep 30, 2025 | 544,700.00 |
| Jun 30, 2025 | 964,389.00 |
| Jun 30, 2025 | 964,389.00 |
| Jun 30, 2024 | -53,373.00 |
| Jun 30, 2024 | -53,373.00 |
| Mar 31, 2024 | -91,597.00 |
| Mar 31, 2024 | -91,597.00 |
| Dec 31, 2023 | -57,334.00 |
| Dec 31, 2023 | -57,334.00 |
| Sep 30, 2023 | -1.06 Mn |
| Sep 30, 2023 | -1.06 Mn |
| Jun 30, 2023 | -6,141.00 |
| Jun 30, 2023 | -6,141.00 |
| Sep 30, 2021 | -5,156.00 |
| Sep 30, 2021 | -5,156.00 |
| Jun 30, 2021 | -38,171.00 |
| Jun 30, 2021 | -38,171.00 |